SOLV vs TOI
SOLV: A diversified healthcare technology and medical products company formed to drive innovation in clinical care, dental health, and health information management. TOI: The Oncology Institute is a value-based oncology care provider that manages outpatient cancer treatment through a national network of clinics and integrated specialty pharmacies.
Side-by-side fundamentals
| Metric | SOLV | TOI | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $80.47 | $5.19 | |
| Market cap as of 2026-07-30 | $13.9B | $519M | |
| P/E as of 2026-07-30 | 10.71 | n/a | |
| PEG as of 2026-07-30 | 0.04 | n/a | |
| Net margin as of 2026-07-30 | +17.3% | -8.0% | SOLV higher |
| Gross margin as of 2026-07-30 | +53.7% | +15.1% | SOLV higher |
| Operating margin as of 2026-07-30 | +24.5% | -6.0% | SOLV higher |
| ROE as of 2026-07-30 | +30.7% | -482.6% | SOLV higher |
| ROA as of 2026-07-30 | +10.0% | -26.5% | SOLV higher |
| Debt / equity as of 2026-07-30 | 1.06 | 14.58 | SOLV lower |
| Revenue growth (YoY) as of 2026-07-30 | -0.6% | +35.4% | TOI higher |
| Revenue CAGR (3y) SEC XBRL | +0.8% | +25.8% | TOI higher |
| Beta as of 2026-07-30 | 0.58 | 0.37 | |
| 1-year return as of 2026-07-27 close | +7.7% | +41.0% | TOI higher |
Fundamentals: market data, as of 2026-07-30. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.